Both primitive and definitive blood cells are derived from Flk-1+ mesoderm
Author:
Affiliation:
1. Department of Pathology and Immunology,
2. Molecular Cell Biology Program, and
3. Developmental Biology Program, Washington University School of Medicine, St Louis, MO
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/113/3/563/1485959/zh800309000563.pdf
Reference18 articles.
1. flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors.;Yamaguchi;Development,1993
2. Deletion of the selection cassette, but not cis-acting elements, in targeted Flk1-lacZ allele reveals Flk1 expression in multipotent mesodermal progenitors.;Ema;Blood,2006
3. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.;Shalaby;Nature,1995
4. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis.;Shalaby;Cell,1997
5. Haemangioblast commitment is initiated in the primitive streak of the mouse embryo.;Huber;Nature,2004
Cited by 77 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Identification of a mesodermal progenitor for the pro-definitive angio-hematopoietic lineage;2024-08-25
2. Eomes directs the formation of spatially and functionally diverse extra-embryonic hematovascular tissues;2024-08-16
3. Strategies to target and genetically modify the liver sinusoid;Sinusoidal Cells in Liver Diseases;2024
4. Clinical Care Team’s Guide for Awareness on Risk Assessment of Eltrombopag Complicating Acute Kidney Injury in Relapsed Immune Thrombocytopenic Patients: A Case Report;Medicina;2023-09-11
5. Therapeutic Outcomes of High Dose-Dexamethasone versus Prednisolone + Azathioprine, Rituximab, Eltrombopag, and Romiplostim Strategies in Persistent, Chronic, Refractory, and Relapsed Immune Thrombocytopenia Patients;Pharmaceuticals;2023-08-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3